Clinical Trials Directory

Trials / Completed

CompletedNCT05565339

PMEI Post-Market Clinical Follow-Up

Status
Completed
Phase
Study type
Observational
Enrollment
497 (actual)
Sponsor
MED-EL Elektromedizinische Geräte GesmbH · Industry
Sex
All
Age
0 Years – 99 Years
Healthy volunteers

Summary

Confirm safety and performance of passive middle ear implants (PMEIs) in subjects with pre-existing condition which made the implantation of a MED-EL PMEI necessary

Detailed description

Collect retrospective audiological and safety results of PMEI implanted subjects. A post-operative minimum and maximum follow-up period was not defined. The mean of the post-operative follow-up period of all patients was calculated.

Conditions

Interventions

TypeNameDescription
DEVICEPMEIsTo evaluate audiological outcomes post-operatively, the air-bone gap (ABG) was assessed. To evaluate safety of the devices, adverse events were collected.A post-operative minimum and maximum follow-up period was not defined. The mean of the post-operative follow-up period of all patients was calculated. To assess whether implantation of PMEI affected residual hearing pre- and post-operative bone conduction thresholds were evaluated.

Timeline

Start date
2020-09-29
Primary completion
2023-11-02
Completion
2023-11-02
First posted
2022-10-04
Last updated
2023-12-15

Locations

11 sites across 3 countries: Austria, Germany, Poland

Source: ClinicalTrials.gov record NCT05565339. Inclusion in this directory is not an endorsement.